166 related articles for article (PubMed ID: 7779721)
1. Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma.
Mulder JW; Baas IO; Polak MM; Goodman SN; Offerhaus GJ
Br J Cancer; 1995 Jun; 71(6):1257-62. PubMed ID: 7779721
[TBL] [Abstract][Full Text] [Related]
2. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
4. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms.
Baas IO; Mulder JW; Offerhaus GJ; Vogelstein B; Hamilton SR
J Pathol; 1994 Jan; 172(1):5-12. PubMed ID: 7931827
[TBL] [Abstract][Full Text] [Related]
7. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance.
Yamaguchi A; Nakagawara G; Kurosaka Y; Nishimura G; Yonemura Y; Miyazaki I
Br J Cancer; 1993 Aug; 68(2):399-402. PubMed ID: 8347496
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Zhang H; Stål O; Wingren S; Hatschek T; Nordenskjöld B
Lancet; 1992 Dec; 340(8832):1369-73. PubMed ID: 1360088
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas.
Sun XF; Carstensen JM; Zhang H; Arbman G; Nordenskjöld B
Eur J Cancer; 1996 Oct; 32A(11):1963-7. PubMed ID: 8943682
[TBL] [Abstract][Full Text] [Related]
10. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Påhlman L; Glimelius B
Anticancer Res; 1996; 16(2):951-7. PubMed ID: 8687158
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
13. Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas.
McKay JA; Lloret C; Murray GI; Johnston PG; Bicknell R; Ahmed FY; Cassidy J; McLeod HL
Int J Oncol; 2000 Jul; 17(1):153-8. PubMed ID: 10853033
[TBL] [Abstract][Full Text] [Related]
14. [P53 protein in adenocarcinoma of the large intestine].
Paluszkiewicz P; Pawłowska-Wakowicz B; Cybulski M; Berbeć H
Wiad Lek; 1997; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410
[TBL] [Abstract][Full Text] [Related]
15. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis.
Flamini G; Curigliano G; Ratto C; Astone A; Ferretti G; Nucera P; Sofo L; Sgambato A; Boninsegna A; Crucitti F; Cittadini A
Eur J Cancer; 1996 May; 32A(5):802-6. PubMed ID: 9081357
[TBL] [Abstract][Full Text] [Related]
17. Protein markers in colorectal cancer: predictors of liver metastasis.
Berney CR; Fisher RJ; Yang J; Russell PJ; Crowe PJ
Ann Surg; 1999 Aug; 230(2):179-84. PubMed ID: 10450731
[TBL] [Abstract][Full Text] [Related]
18. Serum p53 antibody as a useful marker for monitoring of treatment of superficial colorectal adenocarcinoma after endoscopic resection.
Takeda A; Shimada H; Nakajima K; Yoshimura S; Suzuki T; Asano T; Ochiai T; Isono K
Int J Clin Oncol; 2001 Feb; 6(1):45-9. PubMed ID: 11706527
[TBL] [Abstract][Full Text] [Related]
19. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
[TBL] [Abstract][Full Text] [Related]
20. p53 protein expression in colorectal adenomas: an immunohistochemical study using an antigen retrieval system.
Karamitopoulou E; Perentes E; Diamantis I; Vogt U; Wegmann W
Histopathology; 1995 Dec; 27(6):517-23. PubMed ID: 8838331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]